what was the first glp 1 Reflections on discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions History of glucagon-like peptide-1 receptor

No evidence of perforation or mass was seen

Based on this review, evidence from head-to-head and insulin-comparator trials demonstrates that dual GIP/GLP-1 co-agonism consistently overcomes metabolic plateaus that result from single-pathway therapy, producing superior glycated hemoglobin reduction, bariatric-level weight loss (up to 25.3%), and robust macrovascular and heart failure protection, including a 38% reduction in composite cardiovascular risk among patients with heart failure with preserved ejection fraction (HFpEF)

The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for the treatment of obesity

Weight-loss blockbuster or retinal wildcard

Overall Snapshot (High-Level Verdict)Primal Queen PQ7 Daily Support is a botanical appetite and cravings support supplement intended to gently support hunger awareness and meal satisfaction

See how Modballs protein balls use protein, fiber & healthy fats to support appetite control.